Nifty
Sensex
:
:
10564.05
34415.58
-1.25 (-0.01%)
-11.71 (-0.03%)

Pharmaceuticals & Drugs

Rating :
54/99

BSE: 506943 | NSE: JBCHEPHARM

315.65
-5.75 (-1.79%)
20-Apr-2018 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 303.00
  • 318.35
  • 298.65
  • 321.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 313875
  • 990.75
  • 362.80
  • 259.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,675.07
  • 18.06
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,710.55
  • 0.31%
  • 1.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.84%
  • 3.40%
  • 20.85%
  • FII
  • DII
  • Others
  • 0.07%
  • 10.56%
  • 9.28%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
-
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
890.79
756.88
717.09
564.65
Net Sales Growth
-
11.10%
7.64%
11.97%
17.98%
8.01%
-9.98%
17.69%
5.55%
27.00%
 
Cost Of Goods Sold
-
552.00
491.41
341.40
413.95
371.52
320.07
277.04
178.72
187.62
141.11
Gross Profit
-
816.32
740.17
802.81
607.92
494.60
481.80
613.75
578.17
529.48
423.54
GP Margin
-
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
68.90%
76.39%
73.84%
75.01%
Total Expenditure
-
1,139.55
1,025.55
964.09
873.67
760.48
701.55
698.43
589.89
660.24
501.05
Power & Fuel Cost
-
54.89
55.28
53.02
46.61
39.75
29.89
23.34
18.04
15.97
16.59
% Of Sales
-
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
2.62%
2.38%
2.23%
2.94%
Employee Cost
-
206.54
175.31
159.56
143.67
130.05
112.66
124.93
91.71
87.82
85.83
% Of Sales
-
15.09%
14.23%
13.94%
14.06%
15.02%
14.05%
14.02%
12.12%
12.25%
15.20%
Manufacturing Exp.
-
131.45
119.35
223.53
102.44
61.75
52.97
60.85
102.74
108.00
77.49
% Of Sales
-
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
6.83%
13.57%
15.06%
13.72%
General & Admin Exp.
-
42.26
34.82
32.46
31.69
27.94
31.31
38.21
46.25
38.44
37.53
% Of Sales
-
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
4.29%
6.11%
5.36%
6.65%
Selling & Distn. Exp.
-
89.07
72.72
75.13
73.59
56.04
68.65
131.60
110.03
103.83
102.29
% Of Sales
-
6.51%
5.90%
6.57%
7.20%
6.47%
8.56%
14.77%
14.54%
14.48%
18.12%
Miscellaneous Exp.
-
63.34
76.65
79.01
61.72
73.44
86.00
42.47
42.41
118.56
102.29
% Of Sales
-
4.63%
6.22%
6.91%
6.04%
8.48%
10.72%
4.77%
5.60%
16.53%
7.12%
EBITDA
-
228.77
206.03
180.12
148.19
105.65
100.32
192.36
166.99
56.85
63.60
EBITDA Margin
-
16.72%
16.73%
15.74%
14.50%
12.20%
12.51%
21.59%
22.06%
7.93%
11.26%
Other Income
-
53.77
56.65
10.89
37.70
27.87
28.98
6.16
14.21
15.80
15.01
Interest
-
5.37
10.65
6.82
5.93
5.28
24.03
10.49
11.57
15.17
18.03
Depreciation
-
47.22
41.22
38.64
28.02
24.66
22.42
22.79
21.57
20.43
16.90
PBT
-
229.94
210.82
145.55
151.94
103.57
82.85
165.24
148.07
37.06
43.69
Tax
-
45.55
49.58
45.14
25.95
24.13
165.53
25.92
29.32
11.35
-1.63
Tax Rate
-
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
15.69%
19.80%
30.63%
-3.73%
PAT
-
184.06
161.14
100.41
61.50
79.44
677.91
139.32
118.75
25.71
45.32
PAT before Minority Interest
-
184.40
161.24
100.41
61.50
79.44
677.91
139.32
118.75
25.71
45.32
Minority Interest
-
-0.34
-0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
15.64%
15.69%
3.59%
8.03%
PAT Growth
-
14.22%
60.48%
63.27%
-22.58%
-88.28%
386.58%
17.32%
361.88%
-43.27%
 
Unadjusted EPS
-
21.42
19.14
11.84
7.26
9.38
80.11
16.50
14.08
3.05
5.37

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
691.54
568.12
468.89
453.02
Share Capital
16.96
16.96
16.96
16.95
16.94
16.94
16.90
16.87
16.87
16.87
Total Reserves
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
674.31
550.81
451.58
435.71
Non-Current Liabilities
26.98
31.02
32.62
31.93
40.45
39.52
36.50
152.63
191.61
211.83
Secured Loans
0.00
0.00
0.00
0.09
0.22
0.40
0.54
98.49
134.30
154.50
Unsecured Loans
0.00
0.00
0.40
0.40
7.03
12.14
11.99
38.29
44.47
41.86
Long Term Provisions
12.56
10.43
12.03
12.19
8.23
8.27
7.71
0.00
0.00
0.00
Current Liabilities
693.46
797.22
459.75
276.27
239.48
188.32
271.33
116.55
85.81
76.45
Trade Payables
98.98
90.85
77.51
60.75
60.51
37.09
50.21
43.28
34.55
43.73
Other Current Liabilities
122.15
138.73
103.74
98.06
101.15
78.75
61.22
39.53
30.10
17.68
Short Term Borrowings
48.86
193.02
126.88
81.71
37.28
55.23
133.36
0.00
0.00
0.00
Short Term Provisions
423.47
374.61
151.62
35.76
40.54
17.26
26.54
33.74
21.16
15.05
Total Liabilities
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
999.37
837.30
746.31
741.30
Net Block
679.44
440.22
328.56
310.55
334.41
276.31
258.39
246.78
246.71
259.29
Gross Block
1,038.55
753.75
601.67
540.54
537.46
456.51
420.25
386.67
366.57
359.92
Accumulated Depreciation
359.10
313.53
273.11
229.99
203.06
180.19
161.85
139.89
119.86
100.63
Non Current Assets
879.15
831.58
586.31
370.37
356.49
331.58
278.78
271.13
260.89
269.10
Capital Work in Progress
3.76
134.89
55.17
46.36
4.81
39.00
3.75
0.08
6.69
2.29
Non Current Investment
185.84
231.42
184.83
2.75
2.99
3.00
3.94
24.27
7.49
7.52
Long Term Loans & Adv.
9.22
22.63
17.74
10.71
14.28
13.27
12.70
0.00
0.00
0.00
Other Non Current Assets
0.88
2.43
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,207.14
1,182.16
900.94
980.65
943.71
866.22
720.60
566.17
485.42
472.21
Current Investments
224.96
247.28
366.78
497.26
394.68
298.92
81.05
0.00
0.00
0.00
Inventories
200.17
187.98
150.27
134.40
104.53
101.03
111.67
83.81
80.77
74.69
Sundry Debtors
265.97
272.64
262.35
235.51
191.27
136.05
345.58
344.82
302.80
322.42
Cash & Bank
13.39
12.90
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96
Other Current Assets
502.66
2.51
0.38
0.20
96.99
110.69
55.41
59.68
58.00
60.13
Short Term Loans & Adv.
502.60
458.83
95.97
101.48
96.84
110.29
54.66
59.58
57.87
60.13
Net Current Assets
513.68
384.94
441.19
704.37
704.23
677.90
449.27
449.62
399.61
395.75
Total Assets
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80
999.38
837.30
746.31
741.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
200.20
140.41
126.66
-13.98
84.20
879.69
133.92
121.97
91.11
28.31
PBT
229.94
212.23
145.55
87.44
103.57
843.44
165.34
148.07
37.06
43.69
Adjustment
15.32
-1.40
38.51
20.75
-4.40
33.13
16.60
25.01
63.44
35.22
Changes in Working Capital
2.77
-16.96
-19.52
-93.71
9.47
167.35
-15.87
-22.77
1.75
-42.73
Cash after chg. in Working capital
248.04
193.88
164.53
14.49
108.65
1,043.91
166.07
150.31
102.25
36.18
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
-32.15
-28.33
-11.14
-7.87
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-43.55
-27.62
-111.89
-142.50
-116.05
-260.92
-89.46
-29.46
-14.31
-28.06
Net Fixed Assets
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
-32.72
-10.92
-13.11
-28.00
Net Investments
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
-60.83
-16.87
-2.68
-9.37
Others
41.42
174.30
19.13
15.39
21.67
23.05
4.09
-1.67
1.48
9.31
Cash from Financing Activity
-182.90
-99.62
-1.39
12.04
-31.45
-526.12
4.56
-58.49
-47.91
-5.67
Net Cash Inflow / Outflow
-26.26
13.17
13.38
-144.43
-63.30
92.65
49.02
34.02
28.88
-5.42
Opening Cash & Equivalents
9.42
-5.46
11.81
156.23
219.53
126.89
77.86
43.85
14.96
20.39
Closing Cash & Equivalent
-16.83
9.42
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
160.77
139.57
117.31
123.07
119.21
113.34
80.86
66.82
55.35
53.53
ROA
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
15.17%
15.00%
3.46%
6.24%
ROE
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
22.35%
23.05%
5.60%
10.43%
ROCE
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
22.63%
23.71%
8.07%
9.95%
Fixed Asset Turnover
1.53
1.82
2.03
1.92
1.76
1.85
2.22
2.03
2.00
1.74
Receivable days
71.84
79.28
78.41
75.30
68.16
108.62
140.48
154.96
157.34
198.66
Inventory Days
51.77
50.12
44.83
42.16
42.80
47.97
39.77
39.38
39.12
49.46
Payable days
32.86
32.45
27.82
26.91
26.15
26.89
25.89
27.07
26.89
43.96
Cash Conversion Cycle
90.75
96.95
95.43
90.54
84.81
129.69
154.35
167.27
169.57
204.15
Total Debt/Equity
0.04
0.16
0.13
0.09
0.05
0.07
0.25
0.24
0.38
0.44
Interest Cover
43.81
20.80
22.33
15.74
20.61
36.10
16.75
13.80
3.44
3.42

News Update:


  • JB Chemicals receives order for closure of formulation manufacturing facility at Daman
    20th Apr 2018, 09:11 AM

    The company has received an order from Office of Member Secretary, Pollution Control Committee, Daman directing the closure of facility

    Read More
  • JB Chem & Pharma - Quarterly Results
    9th Feb 2018, 14:05 PM

    Read More
  • JB Chemicals receives EU approval for manufacturing facilities at Panoli
    17th Jan 2018, 09:13 AM

    The company’s manufacturing facility at Daman already enjoys EU approval for tablets and lozenges dosage forms

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.